Literature DB >> 1580688

Tuberculin skin reactivity four years after neonatal BCG vaccination.

L P Ormerod1, J M Garnett.   

Abstract

Two hundred and sixty one of 279 (93.5%) children known to be tuberculin positive shortly after receiving their neonatal BCG vaccination were still tuberculin positive at age 4 years. The results confirm the continuing effectiveness of neonatal BCG at 4 years.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1580688      PMCID： PMC1793354          DOI： 10.1136/adc.67.4.530

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  5 in total

1.  Sensitivity of neonates to tuberculin after BCG vaccination.

Authors:  J W Hadfield; J Allan; W J Windebank
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-12

2.  Heaf test results after neonatal BCG.

Authors:  P A Crawshaw; A H Thomson
Journal:  Arch Dis Child       Date:  1988-12       Impact factor: 3.791

3.  Tuberculin response after neonatal BCG vaccination.

Authors:  L P Ormerod; J M Garnett
Journal:  Arch Dis Child       Date:  1988-12       Impact factor: 3.791

4.  Tuberculin response two years after BCG vaccination at birth.

Authors:  H Grindulis; M I Baynham; P H Scott; R A Thompson; B A Wharton
Journal:  Arch Dis Child       Date:  1984-07       Impact factor: 3.791

5.  Protective effect of BCG vaccination in infant Asians: a case-control study.

Authors:  G E Packe; J A Innes
Journal:  Arch Dis Child       Date:  1988-03       Impact factor: 3.791
  5 in total
  3 in total

Review 1.  BCG and tuberculosis.

Authors:  M J Bannon
Journal:  Arch Dis Child       Date:  1999-01       Impact factor: 3.791

Review 2.  Neonatal BCG immunisation.

Authors:  A Clarke; P Rudd
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

3.  Tuberculin reactivity after neonatal percutaneous BCG immunisation.

Authors:  L P Ormerod; C Palmer
Journal:  Arch Dis Child       Date:  1993-07       Impact factor: 3.791
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.